Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Sanofi-Aventis S.A. ADR (NQ: SNY )

49.71 +0.53 (+1.08%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 5, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 860,507
Open 49.19
Bid (Size) 49.16 (1)
Ask (Size) 50.01 (1)
Prev. Close 49.18
Today's Range 49.17 - 49.78
52wk Range 46.12 - 58.10
Shares Outstanding 1,250,690,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
 
Via Benzinga
Looking Into Sanofi's Recent Short Interest
Sanofi's (NASDAQ:SNY) short percent of float has fallen 25.0% since its last report. The company recently reported that it has 2.31 million shares sold short, which is 0.09% of... 
Via Benzinga

Performance

YTD
-1.93%
-1.93%
1 Month
-0.90%
-0.90%
3 Month
-2.38%
-2.38%
6 Month
-6.30%
-6.30%
1 Year
-2.70%
-2.70%

More News

Read More
How Siga Is Turning Its Biowarfare Soldier Onto This Outbreak ... And The Next
Via Investor's Business Daily
Regeneron's Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
Via Benzinga
A Bearish Sign Appears On Sanofi's Chart
Via Benzinga
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Via Benzinga
Sanofi Ekes Out Narrow Beat As Eczema Giant Scores Massive Gain
Via Investor's Business Daily
3-D Portfolio: Discounts, Diversification, And Dividends
Via Talk Markets
Week In Review: China Biopharma Tops $2.8 Billion In Week's Dealmaking
Via Talk Markets
Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate
Via Benzinga
Sanofi Raises Annual Guidance On Upbeat Q2 Performance
Via Benzinga
Daily Stock Analysis: Sanofi S.A.
Via Talk Markets
A Monoclonal Antibody Treatment For ALS Could Begin Human Trials By 2023, According To Pasithea
Via Benzinga
Earnings Scheduled For July 28, 2022
Via Benzinga
Earnings Outlook For Sanofi
Via Benzinga
Regeneron's Price Target Cut On Dim Prospects For Its Flagship Eye Product
Via Benzinga
Amid RNA Setbacks, Start Up Bets On Sanofi's siRNA Platform
Via Benzinga
Apple, Meta, Pfizer Among Key Companies Reporting In The Week Ahead, As Earning Picks Up Pace
Via Benzinga
Pasithea's Latest Drug Candidate Could Bring New Hope To ALS Patients Without Effective Treatment Options
Via Benzinga
Analyzing Sanofi's Short Interest
Via Benzinga
Clovis Oncology (CLVS) Stock Pops 7% on Supply Agreement
Via InvestorPlace
The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine
Via Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
Via Benzinga
Regeneron-Sanofi's Dupixent Hits Primary Goal In Esophagitis Patients Below 11 Years
Via Benzinga
Sanofi Offloads 17 Products To Neuraxpharm
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.